跳至主要内容
临床试验/CTRI/2019/06/019926
CTRI/2019/06/019926招募中4 期

COMPARATIVE EVALUATION OF EFFICACY AND SAFETY OF METFORMIN AND GLIMEPIRIDE WITH CONCOMITANT ROSUVASTATIN IN PATIENTS OF NON ALCOHOLIC FATTY LIVER DISEASE WITH COEXISTENT TYPE 2 DIABETES MELLITUS

nil0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • o NAFLD diagnosed by suggestive imaging findings (ultrasound) with
  • abnormal aminotransferase levels. AST 50-150 U/L (1 to 3 times the
  • upper limit of normal).
  • o Concomitant with newly diagnosed T2DM.
  • o Subjects between age group 20 â?? 60 years of either sex

排除标准

  • 1. Hypersensitivity to metformin, glimepiride and rosuvastatin.
  • 2. Patients with age group < 20 years and > 60 years.
  • 3. Patients with Type 1 Diabetes and Type 2 diabetes with end stage
  • complications and diabetic ketoacidosis.
  • 4. Pregnancy and lactation.
  • 5. Patients with hypotensive states, thyroid disorders, adrenal insufficiency,
  • heart failure, respiratory disorders tuberculosis, hepatobiliary disease,
  • chronic renal disease.
  • 6. Patients with hepatitis B & C and significantly deranged enzymes (ALT >
  • 3 times normal values)
  • 7. Patients with ascites, inflammatory bowel disease, malignancies, G6PD
  • deficiency.
  • 8. Patients on drugs causing hepatic steatosis.
  • 9. Chronic drug or alcohol abuse (daily intake > 20g (2.5 units) in females
  • and 30g (3.5 units) in males
  • 10. Patients with comorbidities like microvascular complications, recent ( <1
  • year) Myocardial infarction, acute coronary syndrome, stroke, osmotic
  • symptoms, history of ketosis, weight loss of >3 kg in preceding 3 months.
  • 11. Patients on drugs causing fatty liver changes like â?? amiodarone,
  • methotrexate, tamoxifen, antiretroviral drugs, tetracyclines,
  • acetaminophen & corticosteroids.
  • 12. Patients on drugs like cimetidine, gemfibrozil, cyclosporine, digoxin,
  • warfarin, beta blockers, calcium channel blockers, macrolide antibiotics,
  • azole antifungals, cholestyramine, diazoxide, oestrogens, hydantoin,
  • isoniazid, nicotinic acid, phenothiazines, rifampin, thiazide diuretics,
  • urinary alkalinizers, furosemide.
  • 13. Patients with megaloblastic anaemia, myopathy
  • 14. Any trauma, surgery.
  • 15. Patients refusing to give informed consent.

研究者

发起方
nil

相似试验